# A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert

> **NCT04061044** · PHASE3 · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Open Angle Glaucoma and Ocular Hypertension

## Interventions

- **DRUG:** Ophthalmic Insert

## Key facts

- **NCT ID:** NCT04061044
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-10
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-09-22
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2023-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04061044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04061044, "A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04061044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*